Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China
We report and analyze a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Chaoyang District of Beijing and to evaluate the causality between the disease and vaccination. Based on the professional branch of this case, we organized a seminar and we in...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2448023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591702446047232 |
|---|---|
| author | Li Li Jingyi Xu Dongkun Zhang Jianlin Cai Zhen Li Xiaohui Zhang Shuping Li |
| author_facet | Li Li Jingyi Xu Dongkun Zhang Jianlin Cai Zhen Li Xiaohui Zhang Shuping Li |
| author_sort | Li Li |
| collection | DOAJ |
| description | We report and analyze a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Chaoyang District of Beijing and to evaluate the causality between the disease and vaccination. Based on the professional branch of this case, we organized a seminar and we invited specialists in vaccinology, epidemiology, dermatology, infectiology, and immunology to participate in the conference. Specialists evaluated the relevance and causality between the vaccination and disease. The clinical diagnosis of the adolescent was pilomatricoma after receiving recombinant hepatitis B vaccine (CHO cell) which could not be disregarded as an adverse reaction following immunization. Although rare, there is a possibility of developing pilomatricoma after vaccination. This suggests that the implementation process of vaccination should be standardized and that the injection site after vaccination should be nursed properly. |
| format | Article |
| id | doaj-art-63abbfb7048f4399bad30352e5ab9560 |
| institution | Kabale University |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-63abbfb7048f4399bad30352e5ab95602025-01-22T07:05:25ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2024.2448023Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of ChinaLi Li0Jingyi Xu1Dongkun Zhang2Jianlin Cai3Zhen Li4Xiaohui Zhang5Shuping Li6Center for Clinical Evaluation of Vaccines, Chaoyang District Center for Disease Control and Prevention, Beijing, ChinaCenter for Clinical Evaluation of Vaccines, Chaoyang District Center for Disease Control and Prevention, Beijing, ChinaPreventive Health Care, Cuigezhuang Community Health Service Center, ChaoYang District, Beijing, ChinaCenter for Clinical Evaluation of Vaccines, Chaoyang District Center for Disease Control and Prevention, Beijing, ChinaCenter for Clinical Evaluation of Vaccines, Chaoyang District Center for Disease Control and Prevention, Beijing, ChinaPreventive Health Care, Cuigezhuang Community Health Service Center, ChaoYang District, Beijing, ChinaCenter for Clinical Evaluation of Vaccines, Chaoyang District Center for Disease Control and Prevention, Beijing, ChinaWe report and analyze a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Chaoyang District of Beijing and to evaluate the causality between the disease and vaccination. Based on the professional branch of this case, we organized a seminar and we invited specialists in vaccinology, epidemiology, dermatology, infectiology, and immunology to participate in the conference. Specialists evaluated the relevance and causality between the vaccination and disease. The clinical diagnosis of the adolescent was pilomatricoma after receiving recombinant hepatitis B vaccine (CHO cell) which could not be disregarded as an adverse reaction following immunization. Although rare, there is a possibility of developing pilomatricoma after vaccination. This suggests that the implementation process of vaccination should be standardized and that the injection site after vaccination should be nursed properly.https://www.tandfonline.com/doi/10.1080/21645515.2024.2448023Pilomatricomarecombinant hepatitis B vaccine (CHO cell)causality |
| spellingShingle | Li Li Jingyi Xu Dongkun Zhang Jianlin Cai Zhen Li Xiaohui Zhang Shuping Li Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China Human Vaccines & Immunotherapeutics Pilomatricoma recombinant hepatitis B vaccine (CHO cell) causality |
| title | Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China |
| title_full | Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China |
| title_fullStr | Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China |
| title_full_unstemmed | Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China |
| title_short | Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China |
| title_sort | analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis b vaccine cho cell in beijing of china |
| topic | Pilomatricoma recombinant hepatitis B vaccine (CHO cell) causality |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2448023 |
| work_keys_str_mv | AT lili analysisofacaseofpilomatricomainanadolescentafterreceivingrecombinanthepatitisbvaccinechocellinbeijingofchina AT jingyixu analysisofacaseofpilomatricomainanadolescentafterreceivingrecombinanthepatitisbvaccinechocellinbeijingofchina AT dongkunzhang analysisofacaseofpilomatricomainanadolescentafterreceivingrecombinanthepatitisbvaccinechocellinbeijingofchina AT jianlincai analysisofacaseofpilomatricomainanadolescentafterreceivingrecombinanthepatitisbvaccinechocellinbeijingofchina AT zhenli analysisofacaseofpilomatricomainanadolescentafterreceivingrecombinanthepatitisbvaccinechocellinbeijingofchina AT xiaohuizhang analysisofacaseofpilomatricomainanadolescentafterreceivingrecombinanthepatitisbvaccinechocellinbeijingofchina AT shupingli analysisofacaseofpilomatricomainanadolescentafterreceivingrecombinanthepatitisbvaccinechocellinbeijingofchina |